Complementary Use of US FDA's Adverse Event Reporting System and Sentinel Distributed Database to Characterize Direct Oral Anticoagulants Associated Cutaneous Small Vessel Vasculitis

Basic Details
Date
Tuesday, August 27, 2019
Type
Presentation
Medical Product
direct oral anticoagulant (DOAC)
Health Outcome(s)
cutaneous small-vessel vasculitis
Presenter(s)

Mohamed Mohamoud, Casie Horgan, Veronica Sansing-Foster, Elizabeth Dee, Justin Bohn, Oren Shapira, Efe Eworuke, Monica Munoz, Danijela Stojanovic, Lois La Grenade